Neuland Laboratories Limited announced on August 25, 2026, that CRISIL Ratings has reaffirmed its credit ratings for the company. The ‘Long Term Rating’ has been reaffirmed as CRISIL A+/ Positive, with the outlook revised to ‘Positive’. The ‘Short Term Rating’ has been reaffirmed as CRISIL A1. This positive development signals continued confidence in the company’s financial stability and future prospects.
CRISIL Reaffirms Credit Ratings for Neuland Laboratories
On August 25, 2026, Neuland Laboratories Limited disclosed that CRISIL Ratings has reaffirmed the credit ratings assigned to the company. This announcement is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Rating Details
The reaffirmed ratings are as follows:
- Long Term Rating: CRISIL A+/ Positive
- Short Term Rating: CRISIL A1
Furthermore, the outlook for the long-term rating has been revised to ‘Positive’, while the short-term rating has been reaffirmed. These reaffirmations and the positive outlook revision by CRISIL reflect the agency’s ongoing assessment of Neuland Laboratories’ financial strength and operational performance.
This information is provided for the records and consideration of stakeholders.
Source: BSE
